Smith Salley Wealth Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.71M Buy
81,276
+768
+1% +$101K 0.49% 56
2025
Q4
$11M Sell
80,508
-1,105
-1% -$159K 0.54% 50
2025
Q3
$12M Sell
81,613
-1,039
-1% -$144K 0.62% 44
2025
Q2
$10.7M Buy
82,652
+1,508
+2% +$183K 0.62% 46
2025
Q1
$9.69M Buy
81,144
+264
+0.3% +$32.7K 0.64% 47
2024
Q4
$9.38M Buy
80,880
+241
+0.3% +$30.5K 0.6% 45
2024
Q3
$10.9M Buy
80,639
+2,255
+3% +$302K 0.71% 45
2024
Q2
$10.6M Buy
78,384
+4,091
+6% +$557K 0.76% 40
2024
Q1
$9.6M Sell
74,293
-25,400
-25% -$3.07M 0.75% 43
2023
Q4
$11.4M Buy
99,693
+3,809
+4% +$380K 0.74% 44
2023
Q3
$8.73M Buy
95,884
+3,150
+3% +$325K 0.65% 46
2023
Q2
$10.4M Sell
92,734
-528
-0.6% -$55.8K 0.77% 42
2023
Q1
$9.76M Buy
93,262
+1,687
+2% +$176K 0.78% 43
2022
Q4
$10.1M Buy
91,575
+873
+1% +$91.5K 0.87% 39
2022
Q3
$7.92M Buy
90,702
+1,378
+2% +$125K 0.74% 42
2022
Q2
$6.98M Buy
89,324
+3,603
+4% +$297K 0.6% 51
2022
Q1
$7.31M Buy
85,721
+1,206
+1% +$116K 0.55% 52
2021
Q4
$10.1M Sell
84,515
-34,197
-29% -$4.24M 0.72% 45
2021
Q3
$14.7M Buy
118,712
+664
+0.6% +$85.5K 1.16% 33
2021
Q2
$14.2M Buy
118,048
+3,266
+3% +$373K 1.15% 35
2021
Q1
$12.1M Buy
114,782
+6,232
+6% +$632K 1.08% 36
2020
Q4
$11M Buy
108,550
+5,826
+6% +$548K 1.12% 35
2020
Q3
$8.64M Buy
102,724
+39,904
+64% +$3.11M 1.04% 40
2020
Q2
$4.08M Buy
62,820
+1,586
+3% +$105K 0.54% 54
2020
Q1
$3.99M Buy
61,234
+1,749
+3% +$138K 0.66% 47
2019
Q4
$4.69M Sell
59,485
-331
-0.6% -$25.8K 0.62% 52
2019
Q3
$4.76M Buy
+59,816
New +$4.7M 0.68% 47

Other funds holding XYL

Smith Salley Wealth Management's XYL Position: Q1 2026 in Review

Smith Salley Wealth Management increased its Xylem (XYL) stake by 0.95% in Q1 2026, buying an estimated $101K and bringing the position to 81,276 shares worth $9.71M. The position accounts for 0.49% of the portfolio, ranked #56.

Smith Salley Wealth Management first reported a position in XYL in Q3 2019 and has held it in 27 quarters since. The position peaked at $14.7M in Q3 2021. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Smith Salley Wealth Management held 81,276 shares of Xylem worth $9.71M as of Q1 2026.
  • Smith Salley Wealth Management bought 768 Xylem shares in Q1 2026, an estimated $101K.
  • Xylem made up 0.49% of Smith Salley Wealth Management's portfolio in Q1 2026, its #56 holding.
  • Smith Salley Wealth Management first reported a position in Xylem in Q3 2019 and has held it in 27 quarters since.
  • Smith Salley Wealth Management's Xylem position peaked at $14.7M in Q3 2021.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Smith Salley Wealth Management's 13F filing for Q1 2026, filed 16 Apr 2026.